Page last updated: 2024-08-17

carbostyril and Biliary Tract Cancer

carbostyril has been researched along with Biliary Tract Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ojima, H; Okusaka, T; Sakamoto, Y; Tajimi, M; Tanizawa, Y; Yamagishi, S	1

Other Studies

1 other study(ies) available for carbostyril and Biliary Tract Cancer

Article	Year
PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay. Japanese journal of clinical oncology, 2018, Apr-01, Volume: 48, Issue:4 Topics: Biliary Tract Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; Inhibitory Concentration 50; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Pyridines; Quinolones; Signal Transduction; TOR Serine-Threonine Kinases	2018

Article

Year

PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay.

Japanese journal of clinical oncology, 2018, Apr-01, Volume: 48, Issue:4

Topics: Biliary Tract Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; Inhibitory Concentration 50; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Pyridines; Quinolones; Signal Transduction; TOR Serine-Threonine Kinases

2018